The Bard PowerPort litigation involves claims that certain implanted port catheter devices were defectively designed and prone to fracture, migration, or failure inside the body.
These devices are commonly used to deliver chemotherapy, medications, or fluids directly into a patient’s bloodstream. Plaintiffs allege that manufacturers failed to adequately warn doctors and patients about potential risks.
Many lawsuits claim device failures caused severe injuries requiring additional surgeries, hospitalization, or long-term medical treatment.
The Bard PowerPort is an implantable venous access device placed beneath the skin and connected to a catheter inserted into a large vein. It allows repeated access for chemotherapy, blood transfusions, and intravenous treatments.
Some lawsuits allege the catheter material may degrade over time, increasing the risk of cracking or breaking inside the bloodstream.
When fractures occur, device fragments may travel through the body, potentially causing life-threatening complications.
Medical reports examined during litigation evaluate complications linked to implanted port devices, including thrombosis, infections, and catheter embolization.
Experts analyze device materials, mechanical stress factors, and failure rates compared to industry safety standards.
These findings help courts determine whether the device design posed unreasonable risks to patients.
Device cracking or breaking inside the body.
Thrombosis linked to implanted catheter devices.
Fragments traveling through veins or heart.
Bloodstream infections requiring hospitalization.
Blocked blood vessels caused by device fragments.
Additional procedures to remove failed devices.
You may qualify if you received a Bard PowerPort implant and experienced medical complications related to device failure.
Implanted ports used during chemotherapy treatment.
Long-term IV therapy recipients.
Individuals requiring device removal or replacement.
Bard PowerPort lawsuits are progressing through coordinated federal litigation where courts review shared scientific evidence and device safety data.
As discovery continues, additional claims are being filed by patients alleging injuries related to implanted catheter failures.
Compensation varies depending on injury severity, medical treatment, and long-term health effects.
No. Claims are handled on a contingency basis, meaning fees are paid only if compensation is recovered.
Medical records confirming implantation and complications typically help evaluate eligibility.
Yes. Each plaintiff maintains an individual claim while benefiting from shared litigation evidence.
Submit your information for a free case evaluation. You pay nothing unless compensation is recovered.
Start Free Case Review